191 related articles for article (PubMed ID: 28589412)
1. Serum CTX levels and histomorphometric analysis in Src versus RANKL knockout mice.
Takeshita S; Fumoto T; Ito M; Ikeda K
J Bone Miner Metab; 2018 May; 36(3):264-273. PubMed ID: 28589412
[TBL] [Abstract][Full Text] [Related]
2. Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.
Sheng MH; Wergedal JE; Mohan S; Amoui M; Baylink DJ; Lau KH
PLoS One; 2012; 7(4):e35280. PubMed ID: 22536365
[TBL] [Abstract][Full Text] [Related]
3. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.
Pellegrini GG; Morales CC; Wallace TC; Plotkin LI; Bellido T
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27409635
[TBL] [Abstract][Full Text] [Related]
4. Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich repeat kinase 2 in mice causes severe osteopetrosis.
Xing W; Liu J; Cheng S; Vogel P; Mohan S; Brommage R
J Bone Miner Res; 2013 Sep; 28(9):1962-74. PubMed ID: 23526378
[TBL] [Abstract][Full Text] [Related]
5. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.
Thudium CS; Moscatelli I; Flores C; Thomsen JS; Brüel A; Gudmann NS; Hauge EM; Karsdal MA; Richter J; Henriksen K
Calcif Tissue Int; 2014 Jul; 95(1):83-93. PubMed ID: 24838599
[TBL] [Abstract][Full Text] [Related]
6. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
7. GPCR kinase 2 interacting protein 1 (GIT1) regulates osteoclast function and bone mass.
Menon P; Yin G; Smolock EM; Zuscik MJ; Yan C; Berk BC
J Cell Physiol; 2010 Nov; 225(3):777-85. PubMed ID: 20568227
[TBL] [Abstract][Full Text] [Related]
8. Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.
Tudpor K; van der Eerden BC; Jongwattanapisan P; Roelofs JJ; van Leeuwen JP; Bindels RJ; Hoenderop JG
Bone; 2015 Mar; 72():14-22. PubMed ID: 25460576
[TBL] [Abstract][Full Text] [Related]
9. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
[TBL] [Abstract][Full Text] [Related]
10. VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.
Zhang Q; Guo R; Lu Y; Zhao L; Zhou Q; Schwarz EM; Huang J; Chen D; Jin ZG; Boyce BF; Xing L
J Biol Chem; 2008 May; 283(19):13491-9. PubMed ID: 18359770
[TBL] [Abstract][Full Text] [Related]
11. The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts.
Huang S; Eleniste PP; Wayakanon K; Mandela P; Eipper BA; Mains RE; Allen MR; Bruzzaniti A
Bone; 2014 Mar; 60():235-45. PubMed ID: 24380811
[TBL] [Abstract][Full Text] [Related]
12. Ablation of Stabilin-1 Enhances Bone-Resorbing Activity in Osteoclasts In Vitro.
Kim SY; Lee EH; Park SY; Choi H; Koh JT; Park EK; Kim IS; Kim JE
Calcif Tissue Int; 2019 Aug; 105(2):205-214. PubMed ID: 31025051
[TBL] [Abstract][Full Text] [Related]
13. Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency.
Thouverey C; Caverzasio J
Endocrinology; 2015 Dec; 156(12):4377-87. PubMed ID: 26441240
[TBL] [Abstract][Full Text] [Related]
14. Proteinase-activated receptor-2 is required for normal osteoblast and osteoclast differentiation during skeletal growth and repair.
Georgy SR; Pagel CN; Ghasem-Zadeh A; Zebaze RM; Pike RN; Sims NA; Mackie EJ
Bone; 2012 Mar; 50(3):704-12. PubMed ID: 22173052
[TBL] [Abstract][Full Text] [Related]
15. Autophagy-linked FYVE containing protein WDFY3 interacts with TRAF6 and modulates RANKL-induced osteoclastogenesis.
Wu DJ; Gu R; Sarin R; Zavodovskaya R; Chen CP; Christiansen BA; Zarbalis KS; Adamopoulos IE
J Autoimmun; 2016 Sep; 73():73-84. PubMed ID: 27330028
[TBL] [Abstract][Full Text] [Related]
16. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.
Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N
Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157
[TBL] [Abstract][Full Text] [Related]
17. Evidence for osteocyte regulation of bone homeostasis through RANKL expression.
Nakashima T; Hayashi M; Fukunaga T; Kurata K; Oh-Hora M; Feng JQ; Bonewald LF; Kodama T; Wutz A; Wagner EF; Penninger JM; Takayanagi H
Nat Med; 2011 Sep; 17(10):1231-4. PubMed ID: 21909105
[TBL] [Abstract][Full Text] [Related]
18. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.
Kato G; Shimizu Y; Arai Y; Suzuki N; Sugamori Y; Maeda M; Takahashi M; Tamura Y; Wakabayashi N; Murali R; Ono T; Ohya K; Mise-Omata S; Aoki K
Arthritis Res Ther; 2015 Sep; 17(1):251. PubMed ID: 26373710
[TBL] [Abstract][Full Text] [Related]
20. Rab27a and Rab27b are involved in stimulation-dependent RANKL release from secretory lysosomes in osteoblastic cells.
Kariya Y; Honma M; Hanamura A; Aoki S; Ninomiya T; Nakamichi Y; Udagawa N; Suzuki H
J Bone Miner Res; 2011 Apr; 26(4):689-703. PubMed ID: 20939018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
